{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:14:07Z","timestamp":1790824447400,"version":"4.1.0"},"reference-count":187,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:00:00Z","timestamp":1632182400000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.autrev.2020.102643","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T21:04:41Z","timestamp":1597439081000},"page":"102643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Anti-rods\/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery"],"prefix":"10.1016","volume":"19","author":[{"given":"S. John","family":"Calise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2020.102643_bb0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ncprheum0895","article-title":"Nature and functions of autoantibodies","volume":"4","author":"Elkon","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0049-0172(95)80004-2","article-title":"Autoantibodies in the diagnosis of systemic rheumatic diseases","volume":"24","author":"von Muhlen","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102643_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/s10165-009-0155-3","article-title":"Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases","volume":"19","author":"Satoh","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0090-1229(88)90066-9","article-title":"Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity","volume":"47","author":"Tan","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2020.102643_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0065-2776(08)60641-0","article-title":"Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology","volume":"44","author":"Tan","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0030","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1586\/1744666X.3.5.721","article-title":"Clinical implication of autoantibodies in patients with systemic rheumatic diseases","volume":"3","author":"Satoh","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014\u20132015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0040","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/annrheumdis-2018-214436","article-title":"Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective","volume":"78","author":"Damoiseaux","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0045","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/ard.2009.127100","article-title":"ANA screening: an old test with new recommendations","volume":"69","author":"Meroni","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000171347","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance","volume":"10","author":"Berg","year":"1992","journal-title":"Dig Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(90)90291-3","article-title":"Anti-actin antibodies: a new test for an old problem","volume":"130","author":"Fusconi","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2020.102643_bb0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2003.10.005","article-title":"Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies","volume":"110","author":"Stinton","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-1-4614-5107-5_2","article-title":"The discovery of GW bodies","volume":"768","author":"Fritzler","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2020.102643_bb0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(91)90356-4","article-title":"Autoantibodies in pathology and cell biology","volume":"67","author":"Tan","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2020.102643_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00351171","article-title":"Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis","volume":"23","author":"Casiano","year":"1996","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2020.102643_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.cdd.4400336","article-title":"Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes","volume":"5","author":"Casiano","year":"1998","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2020.102643_bb0085","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.173.6.1407","article-title":"Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin","volume":"173","author":"Andrade","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0090","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1091\/mbc.01-11-0544","article-title":"A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles","volume":"13","author":"Eystathioy","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.autrev.2020.102643_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/ard.2009.126391","article-title":"Anti-Golgi autoantibodies are not clinically associated with systemic autoimmune diseases","volume":"70","author":"Vermeersch","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0100","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1073\/pnas.76.11.5495","article-title":"Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus","volume":"76","author":"Lerner","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102643_bb0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.autrev.2010.09.025","article-title":"Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F","volume":"10","author":"Fritzler","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102643_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02899205","article-title":"Human autoantibodies: probes for nucleolus structure and function","volume":"54","author":"Reimer","year":"1987","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.autrev.2020.102643_bb0115","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM198109173051223","article-title":"A unique antinuclear antibody staining only the mitotic-spindle apparatus","volume":"305","author":"McCarty","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1084\/jem.178.1.49","article-title":"Molecular characterization of two human autoantigens: unique cDNAs encoding 95- and 160-kD proteins of a putative family in the Golgi complex","volume":"178","author":"Fritzler","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0125","doi-asserted-by":"crossref","first-page":"31262","DOI":"10.1074\/jbc.270.52.31262","article-title":"Molecular characterization of Golgin-245, a novel Golgi complex protein containing a granin signature","volume":"270","author":"Fritzler","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102643_bb0130","doi-asserted-by":"crossref","first-page":"13503","DOI":"10.1074\/jbc.270.22.13503","article-title":"EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine \u201cfingers\u201d and contains a calmodulin-binding IQ motif","volume":"270","author":"Mu","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102643_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029690","article-title":"Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells","volume":"6","author":"Carcamo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102643_bb0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3851\/IMP1993","article-title":"Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C","volume":"17","author":"Covini","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.autrev.2020.102643_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/B978-0-12-800097-7.00002-6","article-title":"Molecular cell biology and immunobiology of mammalian rod\/ring structures","volume":"308","author":"Carcamo","year":"2014","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.autrev.2020.102643_bb0150","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1369\/0022155414543853","article-title":"Ultrastructure of cytoplasmic and nuclear inosine-5\u2032-monophosphate dehydrogenase 2 \u201crods and rings\u201d inclusions","volume":"62","author":"Juda","year":"2014","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.autrev.2020.102643_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jgg.2015.04.002","article-title":"Assembly of IMPDH2-based, CTPS-based, and mixed rod\/ring structures is dependent on cell type and conditions of induction","volume":"42","author":"Keppeke","year":"2015","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.autrev.2020.102643_bb0160","first-page":"753","article-title":"Autoantibodies against inosine-5\u2032-monophosphate dehydrogenase 2--characteristics and prevalence in patients with HCV-infection","volume":"57","author":"Seelig","year":"2011","journal-title":"Clin Lab"},{"issue":"Suppl 2:S2","key":"10.1016\/j.autrev.2020.102643_bb0165","article-title":"Chronic HCV infection: epidemiological and clinical relevance","volume":"12","author":"Zaltron","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0170","doi-asserted-by":"crossref","first-page":"20160274","DOI":"10.1098\/rstb.2016.0274","article-title":"Viral hepatitis and liver cancer","volume":"372","author":"Ringelhan","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0175","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C","volume":"132","author":"Liang","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cld.2005.05.003","article-title":"Natural history of hepatitis C","volume":"9","author":"Thomas","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0185","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0190","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0049-0172(97)80005-4","article-title":"Hepatitis C virus infection and autoimmunity","volume":"26","author":"McMurray","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102643_bb0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0168-8278(05)80281-8","article-title":"Non-organ specific autoantibodies associated with chronic C virus hepatitis","volume":"18","author":"Abuaf","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0200","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2020.102643_bb0205","first-page":"613","article-title":"High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C","volume":"21","author":"Clifford","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2020.102643_bb0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2893.2008.01035.x","article-title":"Autoantibodies in chronic hepatitis C virus infection and their association with disease profile","volume":"16","author":"Williams","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.autrev.2020.102643_bb0215","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.autrev.2011.03.001","article-title":"Autoantibodies to intracellular antigens: generation and pathogenetic role","volume":"10","author":"Racanelli","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102643_bb0220","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2249.2003.02229.x","article-title":"Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection","volume":"133","author":"Gregorio","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.190.2.169","article-title":"Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition","volume":"190","author":"Kammer","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0230","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1073\/pnas.96.5.2279","article-title":"Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease","volume":"96","author":"Misko","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2020.102643_bb0235","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/138161208784746824","article-title":"HCV and autoimmunity","volume":"14","author":"Ferri","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2020.102643_bb0240","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1097-0215(20000715)87:2<211::AID-IJC9>3.0.CO;2-8","article-title":"Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process","volume":"87","author":"De Re","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.autrev.2020.102643_bb0245","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/j.gastro.2005.12.039","article-title":"Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism","volume":"130","author":"Pal","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2020.102643_bb0250","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.autrev.2020.102643_bb0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2249.2002.01844.x","article-title":"Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection","volume":"128","author":"Zuckerman","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0260","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0168-8278(03)00075-8","article-title":"Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver","volume":"38","author":"Curry","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00281-012-0328-6","article-title":"Autoimmune manifestations in viral hepatitis","volume":"35","author":"Vergani","year":"2013","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2020.102643_bb0270","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3748\/wjg.v22.i6.1966","article-title":"Anti-rods\/rings autoantibody generation in hepatitis C patients during interferon-alpha\/ribavirin therapy","volume":"22","author":"Keppeke","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102643_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045392","article-title":"Longitudinal study of a human drug-induced model of autoantibody to cytoplasmic rods\/rings following HCV therapy with ribavirin and interferon-alpha","volume":"7","author":"Keppeke","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102643_bb0280","series-title":"Antibodies to Rods and Rings. Autoantibodies","first-page":"161","author":"Calise","year":"2014"},{"key":"10.1016\/j.autrev.2020.102643_bb0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2015.00041","article-title":"Anti-rods\/rings: a human model of drug-induced autoantibody generation","volume":"6","author":"Calise","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0290","first-page":"561","article-title":"A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis","volume":"55","author":"Homberg","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0295","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3748\/wjg.v9.i7.1487","article-title":"Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy","volume":"9","author":"Fabbri","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102643_bb0300","first-page":"1138","article-title":"High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha","volume":"90","author":"Matsuda","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102643_bb0305","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.48.3.378","article-title":"Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C","volume":"48","author":"Wesche","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2020.102643_bb0310","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF00400426","article-title":"Antibodies to glutamic acid decarboxylase induced by interferon-alpha therapy for chronic viral hepatitis","volume":"39","author":"Imagawa","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.autrev.2020.102643_bb0315","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/00365529609009156","article-title":"Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy","volume":"31","author":"Noda","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102643_bb0320","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","article-title":"Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis","volume":"340","author":"Fabris","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2020.102643_bb0325","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0168-8278(98)80328-0","article-title":"Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis","volume":"28","author":"Fabris","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0330","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/0016-5085(95)90139-6","article-title":"Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C","volume":"108","author":"Garcia-Buey","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2020.102643_bb0335","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1074\/jbc.M507056200","article-title":"Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic Acid by GTP","volume":"281","author":"Ji","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102643_bb0340","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.biocel.2007.12.018","article-title":"Characterisation of inosine monophosphate dehydrogenase expression during retinal development: differences between variants and isoforms","volume":"40","author":"Gunter","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.autrev.2020.102643_bb0345","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1534\/genetics.106.065961","article-title":"The carnegie protein trap library: a versatile tool for Drosophila developmental studies","volume":"175","author":"Buszczak","year":"2007","journal-title":"Genetics"},{"key":"10.1016\/j.autrev.2020.102643_bb0350","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1673-8527(09)60046-1","article-title":"Intracellular compartmentation of CTP synthase in Drosophila","volume":"37","author":"Liu","year":"2010","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.autrev.2020.102643_bb0355","first-page":"3550","article-title":"Cytoophidium assembly reflects upregulation of IMPDH activity","volume":"128","author":"Chang","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0360","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1111\/febs.14624","article-title":"Interfilament interaction between IMPDH and CTPS cytoophidia","volume":"285","author":"Chang","year":"2018","journal-title":"FEBS J"},{"key":"10.1016\/j.autrev.2020.102643_bb0365","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1016\/S0021-9258(19)34120-1","article-title":"Two distinct cDNAs for human IMP dehydrogenase","volume":"265","author":"Natsumeda","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102643_bb0370","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem Rev"},{"key":"10.1016\/j.autrev.2020.102643_bb0375","doi-asserted-by":"crossref","first-page":"27286","DOI":"10.1016\/S0021-9258(19)74247-1","article-title":"Characterization of human type I and type II IMP dehydrogenases","volume":"268","author":"Carr","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102643_bb0380","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1016\/S0021-9258(19)37654-9","article-title":"Cloning and sequence analysis of the human and Chinese hamster inosine-5\u2032-monophosphate dehydrogenase cDNAs","volume":"263","author":"Collart","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102643_bb0385","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0006-2952(95)00026-V","article-title":"Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding","volume":"49","author":"Hager","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2020.102643_bb0390","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bcp.2003.09.043","article-title":"Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes","volume":"67","author":"Jain","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2020.102643_bb0395","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/0024-3205(94)90150-3","article-title":"Tissue-differential expression of two distinct genes for human IMP dehydrogenase (E.C.1.1.1.205)","volume":"54","author":"Senda","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0400","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1167\/iovs.06-0207","article-title":"Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration?","volume":"47","author":"Bowne","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0405","first-page":"1866","article-title":"Characterization of retinal inosine monophosphate dehydrogenase 1 in several mammalian species","volume":"13","author":"Spellicy","year":"2007","journal-title":"Mol Vis"},{"key":"10.1016\/j.autrev.2020.102643_bb0410","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-1-4614-0631-0_68","article-title":"Towards a pathological mechanism for IMPDH1-linked retinitis pigmentosa","volume":"723","author":"McGrew","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2020.102643_bb0415","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2008.02.012","article-title":"Retinal isoforms of inosine 5\u2032-monophosphate dehydrogenase type 1 are poor nucleic acid binding proteins","volume":"472","author":"Xu","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.autrev.2020.102643_bb0420","first-page":"5826","article-title":"Increased inosine-5\u2032-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines","volume":"52","author":"Collart","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2020.102643_bb0425","first-page":"3886","article-title":"Selective up-regulation of type II inosine 5\u2032-monophosphate dehydrogenase messenger RNA expression in human leukemias","volume":"51","author":"Nagai","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2020.102643_bb0430","first-page":"258","article-title":"Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells","volume":"52","author":"Nagai","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2020.102643_bb0435","doi-asserted-by":"crossref","first-page":"984","DOI":"10.4049\/jimmunol.152.3.984","article-title":"Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression","volume":"152","author":"Dayton","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0440","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/hmg\/ddh061","article-title":"On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa","volume":"13","author":"Aherne","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2020.102643_bb0445","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1172\/JCI8669","article-title":"Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene","volume":"106","author":"Gu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2020.102643_bb0450","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0014-4827(87)90162-5","article-title":"A novel fibrillar structure in cultured cells detected by a monoclonal antibody","volume":"171","author":"Willingham","year":"1987","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.autrev.2020.102643_bb0455","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clim.2016.10.004","article-title":"Differential capacity of therapeutic drugs to induce Rods\/Rings structures in vitro and in vivo and generation of anti-Rods\/Rings autoantibodies","volume":"173","author":"Keppeke","year":"2016","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0460","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10875-012-9827-4","article-title":"Differential reactivity to IMPDH2 by anti-rods\/rings autoantibodies and unresponsiveness to pegylated interferon-alpha\/ribavirin therapy in US and Italian HCV patients","volume":"33","author":"Carcamo","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0465","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-230X-13-50","article-title":"Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection","volume":"13","author":"Stinton","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102643_bb0470","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cca.2013.01.003","article-title":"Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against \u201crings and rods\u201d-associated inosine-5\u2019-monophosphate dehydrogenase 2 in viral hepatitis C","volume":"418","author":"Probst","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2020.102643_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3701-5-1","article-title":"Microinjection of specific anti-IMPDH2 antibodies induces disassembly of cytoplasmic rods\/rings that are primarily stationary and stable structures","volume":"5","author":"Keppeke","year":"2015","journal-title":"Cell Biosci"},{"key":"10.1016\/j.autrev.2020.102643_bb0480","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1515\/cclm-2017-1152","article-title":"Reference standards for the detection of anti-mitochondrial and anti-rods\/rings autoantibodies","volume":"56","author":"Calise","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0485","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12026-014-8515-2","article-title":"Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-alpha","volume":"60","author":"Keppeke","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102643_bb0490","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/jvh.12281","article-title":"Interferon-ribavirin therapy induces serum antibodies determining \u2018rods and rings\u2019 pattern in hepatitis C patients","volume":"21","author":"Novembrino","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.autrev.2020.102643_bb0495","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2020.102643_bb0500","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/08916934.2015.1118762","article-title":"Clinical correlates of the \u201crods and rings\u201d antinuclear antibody pattern","volume":"49","author":"Climent","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2020.102643_bb0505","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1242\/jcs.183400","article-title":"\u2018Rod and ring\u2019 formation from IMP dehydrogenase is regulated through the one-carbon metabolic pathway","volume":"129","author":"Calise","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0510","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12848","article-title":"The value of anti-rods and rings antibodies in Western China population: a retrospective study","volume":"91","author":"Zhang","year":"2020","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0515","series-title":"9th Dresden Symposium on Autoantibodies","first-page":"127","article-title":"Cytoplasmic rings\/rods as autoimmune targets of emerging human autoantibodies associated with HCV virus infection and interferon therapy","author":"Carcamo","year":"2009"},{"key":"10.1016\/j.autrev.2020.102643_bb0520","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gastrohep.2018.08.005","article-title":"Autoantibodies to cytoplasmic rods and rings in patients with hepatitis C virus infection treated with direct-acting antivirals: the role of prior treatment with interferon plus ribavirin","volume":"42","author":"Alsius","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0525","first-page":"76","article-title":"Primary biliary cholangitis with contemporary presence of anti-mithocondrial and anti-rods and rings autoantibodies: literature first case","volume":"12","author":"Assandri","year":"2019","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.autrev.2020.102643_bb0530","first-page":"73","article-title":"ANA-Hep2 positive with anti-rods and rings pattern in a child without hepatitis C under treatment: case report","volume":"5","author":"Magerl","year":"2019","journal-title":"J Rheumat Dis Treat"},{"key":"10.1016\/j.autrev.2020.102643_bb0535","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13317-016-0087-9","article-title":"Anti-rods\/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection","volume":"7","author":"Calise","year":"2016","journal-title":"Auto Immun Highlights"},{"key":"10.1016\/j.autrev.2020.102643_bb0540","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00430-017-0516-z","article-title":"Autoantibodies against \u201crods and rings\u201d-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a \u201creal life\u201d cohort","volume":"206","author":"Dammermann","year":"2017","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0545","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ije\/dym096","article-title":"Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS)","volume":"36","author":"Prasad","year":"2007","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.autrev.2020.102643_bb0550","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaut.2019.04.019","article-title":"Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents","volume":"102","author":"Terziroli Beretta-Piccoli","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2020.102643_bb0555","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3748\/wjg.v21.i1.233","article-title":"Interferon therapy in hepatitis C leading to chronic type 1 diabetes","volume":"21","author":"Zornitzki","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2020.102643_bb0560","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/INF.0000000000001791","article-title":"Transient hypothyroidism and autoimmune thyroiditis in children with chronic hepatitis C treated with pegylated-interferon-alpha-2b and ribavirin","volume":"37","author":"Serranti","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.autrev.2020.102643_bb0565","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/MEG.0b013e32816e070b","article-title":"Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C","volume":"19","author":"Yurci","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0570","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1542-3565(05)00018-2","article-title":"Susceptibility to thyroid disorders in hepatitis C","volume":"3","author":"Muratori","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0575","first-page":"73","article-title":"Antibody against distinct cytoplasmic antigens in patients receiving anti-hepatitis C therapy with interferon and ribavirin in Taiwan","volume":"25","author":"Sun","year":"2014","journal-title":"Chung Shan Med J"},{"key":"10.1016\/j.autrev.2020.102643_bb0580","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/vim.2019.0012","article-title":"Association of autoantibody to rods and rings with hepatitis C outcome and viral load","volume":"32","author":"Dhaouadi","year":"2019","journal-title":"Viral Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2020.102643_bb0585","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.ijid.2009.11.032","article-title":"Seroprevalence of hepatitis C virus: the first population-based study from Iran","volume":"14","author":"Merat","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0590","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.42388","article-title":"The presence of autoantibodies to cytoplasmic rod and ring particles in the serum of patients with chronic hepatitis C virus infection","volume":"16","author":"Afsharzadeh","year":"2016","journal-title":"Hepat Mon"},{"key":"10.1016\/j.autrev.2020.102643_bb0595","doi-asserted-by":"crossref","first-page":"53","DOI":"10.30621\/jbachs.2018.408","article-title":"Evaluation of rare antinuclear antibody patterns in a tertiary hospital in \u0130zmir","volume":"2","author":"Sener","year":"2018","journal-title":"J Basic Clin Health Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0600","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3343\/alm.2015.35.6.660","article-title":"Anti-rods and rings autoantibodies in a patient with hepatitis C virus infection","volume":"35","author":"Choi","year":"2015","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0605","doi-asserted-by":"crossref","first-page":"87","DOI":"10.15386\/cjmed-996","article-title":"Long-term antiviral hepatitis C treatment associated with Rods and Ring Cytoplasmic antibodies","volume":"92","author":"Feldrihan","year":"2019","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.autrev.2020.102643_bb0610","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12026-018-9026-3","article-title":"Long-term persistence of anti-rods and rings antibodies in patients with chronic hepatitis C after antiviral treatment","volume":"66","author":"da Silva Sacerdote","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2020.102643_bb0615","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.antiviral.2018.12.017","article-title":"Ribavirin induces widespread accumulation of IMP dehydrogenase into rods\/rings structures in multiple major mouse organs","volume":"162","author":"Keppeke","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.autrev.2020.102643_bb0620","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.223289","article-title":"T cell activation triggers reversible inosine-5\u2032-monophosphate dehydrogenase assembly","volume":"131","author":"Duong-Ly","year":"2018","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0625","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.3389\/fimmu.2018.02789","article-title":"Immune response-dependent assembly of IMP dehydrogenase filaments","volume":"9","author":"Calise","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2020.102643_bb0630","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1083\/jcb.201003001","article-title":"Identification of novel filament-forming proteins in Saccharomyces cerevisiae and Drosophila melanogaster","volume":"190","author":"Noree","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.autrev.2020.102643_bb0635","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jgg.2016.03.008","article-title":"Filamentation of metabolic enzymes in Saccharomyces cerevisiae","volume":"43","author":"Shen","year":"2016","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.autrev.2020.102643_bb0640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051096","article-title":"Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms","volume":"7","author":"Thomas","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2020.102643_bb0645","doi-asserted-by":"crossref","DOI":"10.1093\/jn\/131.9.2449S","article-title":"Glutamine: the emperor or his clothes?","volume":"131","author":"Young","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.autrev.2020.102643_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbf.1003","article-title":"Glutamine and glutamate--their central role in cell metabolism and function","volume":"21","author":"Newsholme","year":"2003","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.autrev.2020.102643_bb0655","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jcp.20339","article-title":"Molecular mechanisms of glutamine action","volume":"204","author":"Curi","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2020.102643_bb0660","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1042\/bj2610979","article-title":"The effect of glutamine concentration on the activity of carbamoyl-phosphate synthase II and on the incorporation of [3H]thymidine into DNA in rat mesenteric lymphocytes stimulated by phytohaemagglutinin","volume":"261","author":"Szondy","year":"1989","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2020.102643_bb0665","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj2700437","article-title":"The effect of various concentrations of nucleobases, nucleosides or glutamine on the incorporation of [3H]thymidine into DNA in rat mesenteric-lymph-node lymphocytes stimulated by phytohaemagglutinin","volume":"270","author":"Szondy","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2020.102643_bb0670","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s003940050074","article-title":"Role of glutamine on the de novo purine nucleotide synthesis in Caco-2 cells","volume":"39","author":"Boza","year":"2000","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.autrev.2020.102643_bb0675","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0680","first-page":"9","article-title":"Advances in the enzymology of glutamine synthesis","volume":"72","author":"Purich","year":"1998","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"10.1016\/j.autrev.2020.102643_bb0685","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s00018-014-1567-6","article-title":"Glutamine deprivation initiates reversible assembly of mammalian rods and rings","volume":"71","author":"Calise","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2020.102643_bb0690","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/256331a0","article-title":"IMP dehydrogenase, an enzyme linked with proliferation and malignancy","volume":"256","author":"Jackson","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2020.102643_bb0695","first-page":"207","article-title":"The role of de novo purine synthesis in lymphocyte transformation","volume":"48","author":"Allison","year":"1977","journal-title":"Ciba Found Symp"},{"key":"10.1016\/j.autrev.2020.102643_bb0700","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13008-018-0038-0","article-title":"IMP\/GTP balance modulates cytoophidium assembly and IMPDH activity","volume":"13","author":"Keppeke","year":"2018","journal-title":"Cell Div"},{"key":"10.1016\/j.autrev.2020.102643_bb0705","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.aad0489","article-title":"mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle","volume":"351","author":"Ben-Sahra","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.autrev.2020.102643_bb0710","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ccell.2017.09.013","article-title":"mTORC1 couples nucleotide synthesis to nucleotide demand resulting in a targetable metabolic vulnerability","volume":"32","author":"Valvezan","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.autrev.2020.102643_bb0715","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.immuni.2017.09.003","article-title":"Store-operated Ca(2+) entry controls clonal expansion of T cells through metabolic reprogramming","volume":"47","author":"Vaeth","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2020.102643_bb0720","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/j.celrep.2017.05.043","article-title":"Purine nucleotide availability regulates mTORC1 activity through the Rheb GTPase","volume":"19","author":"Emmanuel","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2020.102643_bb0725","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.celrep.2017.10.029","article-title":"The mTORC1 signaling network senses changes in cellular purine nucleotide levels","volume":"21","author":"Hoxhaj","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2020.102643_bb0730","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1038\/s41598-017-02805-x","article-title":"A nucleotide-controlled conformational switch modulates the activity of eukaryotic IMP dehydrogenases","volume":"7","author":"Buey","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2020.102643_bb0735","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jmb.2019.01.020","article-title":"A nucleotide-dependent conformational switch controls the polymerization of human IMP dehydrogenases to modulate their catalytic activity","volume":"431","author":"Fernandez-Justel","year":"2019","journal-title":"J Mol Biol"},{"key":"10.1016\/j.autrev.2020.102643_bb0740","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1038\/ncomms9923","article-title":"Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases","volume":"6","author":"Buey","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2020.102643_bb0745","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.str.2013.03.011","article-title":"MgATP regulates allostery and fiber formation in IMPDHs","volume":"21","author":"Labesse","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.autrev.2020.102643_bb0750","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1091\/mbc.e17-04-0263","article-title":"Reconstituted IMPDH polymers accommodate both catalytically active and inactive conformations","volume":"28","author":"Anthony","year":"2017","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.autrev.2020.102643_bb0755","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53243","article-title":"Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation","volume":"9","author":"Johnson","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.autrev.2020.102643_bb0760","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/cancers11050688","article-title":"Cancer cells tune the signaling pathways to empower de novo synthesis of nucleotides","volume":"11","author":"Villa","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.autrev.2020.102643_bb0765","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/prep.1999.1136","article-title":"Biochemical analysis of the modular enzyme inosine 5\u2032-monophosphate dehydrogenase","volume":"17","author":"Nimmesgern","year":"1999","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.autrev.2020.102643_bb0770","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2958.2008.06153.x","article-title":"The CBS subdomain of inosine 5\u2032-monophosphate dehydrogenase regulates purine nucleotide turnover","volume":"68","author":"Pimkin","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.autrev.2020.102643_bb0775","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj20031585","article-title":"Inosine 5\u2032-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo","volume":"379","author":"McLean","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2020.102643_bb0780","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0300-9084(02)01400-1","article-title":"Participation of yeast inosine 5\u2032-monophosphate dehydrogenase in an in vitro complex with a fragment of the C-rich telomeric strand","volume":"84","author":"Cornuel","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.autrev.2020.102643_bb0785","doi-asserted-by":"crossref","first-page":"36354","DOI":"10.1074\/jbc.M806143200","article-title":"IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNA","volume":"283","author":"Mortimer","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102643_bb0790","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/BJ20042051","article-title":"Autosomal dominant retinitis pigmentosa mutations in inosine 5\u2032-monophosphate dehydrogenase type I disrupt nucleic acid binding","volume":"390","author":"Mortimer","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.autrev.2020.102643_bb0795","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2012.04.030","article-title":"Metabolic enzyme IMPDH is also a transcription factor regulated by cellular state","volume":"47","author":"Kozhevnikova","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.autrev.2020.102643_bb0800","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(00)01866-4","article-title":"PKB\/Akt interacts with inosine-5\u2032 monophosphate dehydrogenase through its pleckstrin homology domain","volume":"478","author":"Ingley","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2020.102643_bb0805","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1600-0854.2004.00217.x","article-title":"Insulin and oleate promote translocation of inosine-5\u2032 monophosphate dehydrogenase to lipid bodies","volume":"5","author":"Whitehead","year":"2004","journal-title":"Traffic"},{"key":"10.1016\/j.autrev.2020.102643_bb0810","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1074\/jbc.RA119.008231","article-title":"ANKRD9 is a metabolically-controlled regulator of IMPDH2 abundance and macro-assembly","volume":"294","author":"Hayward","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2020.102643_bb0815","first-page":"3145","article-title":"ANKRD9 is associated with tumor suppression as a substrate receptor subunit of ubiquitin ligase","volume":"2018","author":"Lee","year":"1864","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0820","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cell.2015.06.043","article-title":"The BioPlex network: a systematic exploration of the human interactome","volume":"162","author":"Huttlin","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2020.102643_bb0825","doi-asserted-by":"crossref","first-page":"568","DOI":"10.5483\/BMBRep.2009.42.9.568","article-title":"Regulation of ANKRD9 expression by lipid metabolic perturbations","volume":"42","author":"Wang","year":"2009","journal-title":"BMB Rep"},{"key":"10.1016\/j.autrev.2020.102643_bb0830","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1534\/genetics.115.180737","article-title":"Regulation of CTP synthase filament formation during DNA endoreplication in drosophila","volume":"201","author":"Wang","year":"2015","journal-title":"Genetics"},{"key":"10.1016\/j.autrev.2020.102643_bb0835","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/19336934.2016.1182268","article-title":"Ubiquitination and filamentous structure of cytidine triphosphate synthase","volume":"10","author":"Pai","year":"2016","journal-title":"Fly"},{"key":"10.1016\/j.autrev.2020.102643_bb0840","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3321","article-title":"A subcellular map of the human proteome","volume":"356","author":"Thul","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.autrev.2020.102643_bb0845","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nbt.4225","article-title":"Deep learning is combined with massive-scale citizen science to improve large-scale image classification","volume":"36","author":"Sullivan","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.autrev.2020.102643_bb0850","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1091\/mbc.E18-05-0274","article-title":"Compositional complexity of rods and rings","volume":"29","author":"Schiavon","year":"2018","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.autrev.2020.102643_bb0855","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1365-2036.2006.03165.x","article-title":"Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C","volume":"24","author":"Gatselis","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2020.102643_bb0860","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2334-4-4","article-title":"The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C","volume":"4","author":"Wasmuth","year":"2004","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0865","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1086\/427285","article-title":"Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C","volume":"40","author":"Muratori","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2020.102643_bb0870","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/MEG.0b013e3283089392","article-title":"Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?","volume":"21","author":"Narciso-Schiavon","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0875","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2893.2004.00530.x","article-title":"Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance","volume":"11","author":"Yee","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.autrev.2020.102643_bb0880","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/jvh.12011","article-title":"Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome","volume":"20","author":"Mauss","year":"2013","journal-title":"J Viral Hepat"},{"issue":"Suppl. 5","key":"10.1016\/j.autrev.2020.102643_bb0885","first-page":"803","article-title":"Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus","volume":"107","author":"Rubin","year":"1999","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.autrev.2020.102643_bb0890","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/14740338.2015.995089","article-title":"Drug-induced lupus","volume":"14","author":"Rubin","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.autrev.2020.102643_bb0895","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/BOR.0b013e32832f13db","article-title":"Drug-induced autoimmunity","volume":"21","author":"Dedeoglu","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0900","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.autrev.2005.01.002","article-title":"Current trends in drug-induced autoimmunity","volume":"4","author":"Uetrecht","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2020.102643_bb0905","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrrheum.2013.184","article-title":"Autoantibodies and SLE: the threshold for disease","volume":"10","author":"Olsen","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2020.102643_bb0910","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/0961203310385738","article-title":"Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity","volume":"20","author":"Ippolito","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2020.102643_bb0915","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/liv.13212","article-title":"Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection","volume":"37","author":"Feld","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.autrev.2020.102643_bb0920","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0925","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0930","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.179.4.1243","article-title":"Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen","volume":"179","author":"Dong","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2020.102643_bb0935","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Consortium","year":"2019","journal-title":"Nucleic Acids Res"}],"updated-by":[{"DOI":"10.1016\/j.autrev.2021.102766","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000}}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997220302147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:18:54Z","timestamp":1761599934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997220302147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":187,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1568997220302147"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102643","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-rods\/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2020.102643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102643"}}